High-Intensity Interval Training for Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different lengths of high-intensity interval training (HIIT) might benefit people with type 2 diabetes. The researchers aim to determine if longer workout intervals can reduce inflammation, lower blood pressure, and increase blood vessel flexibility, potentially reducing heart problem risks. Participants will engage in two types of HIIT workouts—one with shorter intervals and one with longer intervals—to compare the effects. This trial suits individuals with type 2 diabetes who manage their blood pressure, consume little or no alcohol, do not smoke, and are already somewhat active. As an unphased trial, it offers a unique opportunity to contribute to understanding how HIIT can benefit those with type 2 diabetes.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on insulin therapy or beta blockers, or if your medication has been unstable in the past 6 months.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that high-intensity interval training (HIIT) is generally safe for people with various health conditions. Studies have found that individuals with heart issues and those over 67 years old can safely engage in HIIT by monitoring heart rate, blood pressure, and other health indicators.
For the HIIT-10 program, evidence suggests it is safe and well-tolerated in various settings, including for those with heart diseases, with no major safety issues reported.
Similarly, the HIIT-4 program has a strong safety record. Research supports its safety for improving exercise ability and other health aspects in different groups, including those with liver conditions.
In summary, both HIIT-10 and HIIT-4 appear to be safe options based on past research. They are well-tolerated and have been tested in different groups without significant safety problems.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different lengths of high-intensity interval training (HIIT) sessions might reduce complications linked to Type 2 Diabetes. Unlike standard treatments like medication or continuous moderate exercise, HIIT offers a time-efficient workout that can potentially improve cardiovascular health and glucose metabolism quicker. The trial will help determine whether shorter or longer HIIT intervals offer more significant clinical benefits, providing insights into optimizing exercise prescriptions for those managing Type 2 Diabetes.
What evidence suggests that this trial's treatments could be effective for reducing cardiovascular disease risk in type 2 diabetes patients?
Studies have shown that high-intensity interval training (HIIT) effectively improves health in people with type 2 diabetes. Research indicates that HIIT significantly enhances blood vessel function by lowering blood pressure. This exercise also boosts aerobic capacity, aiding heart and lung function. It improves body composition by reducing bad cholesterol and enhancing other key health indicators. In this trial, participants will experience both HIIT-10 and HIIT-4, which have demonstrated these benefits, though the different interval lengths might yield slightly different results. Overall, HIIT offers a promising approach to managing diabetes and reducing the risk of complications like heart disease.46789
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Rest
Participants undergo a rest condition as a baseline measure before HIIT interventions
HIIT-4
Participants perform high-intensity interval training with 4x4 minute intervals
HIIT-10
Participants perform high-intensity interval training with 10x1 minute intervals
Follow-up
Participants are monitored for changes in clinical parameters such as blood pressure and glycemic control
What Are the Treatments Tested in This Trial?
Interventions
- High-intensity interval training (HIIT)-10
- High-intensity interval training (HIIT)-4
- Rest
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Sherbrooke
Lead Sponsor